Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
24.70
+0.11 (0.45%)
Apr 15, 2026, 3:00 PM CST
SHA:603983 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,250 | 2,032 | 1,077 | 1,073 | 806.1 |
Short-Term Investments | 154.42 | 44.08 | 279.64 | 333.41 | 115.15 |
Trading Asset Securities | 388.66 | 395.7 | 767.98 | 437.78 | 738.09 |
Cash & Short-Term Investments | 1,793 | 2,472 | 2,124 | 1,844 | 1,659 |
Cash Growth | -27.45% | 16.36% | 15.19% | 11.14% | -33.37% |
Accounts Receivable | 38.4 | 46.43 | 31.5 | 73.93 | 62.85 |
Other Receivables | 22.12 | 11.57 | 14.64 | 7.43 | 7.42 |
Receivables | 60.52 | 58 | 46.14 | 81.36 | 70.26 |
Inventory | 233.35 | 219.66 | 171.73 | 151.7 | 138.43 |
Prepaid Expenses | 9.18 | 12.52 | - | - | 4.9 |
Other Current Assets | 139.34 | 192.31 | 187.75 | 159.99 | 102.88 |
Total Current Assets | 2,236 | 2,954 | 2,530 | 2,237 | 1,976 |
Property, Plant & Equipment | 931.77 | 1,082 | 769.91 | 520.59 | 384.14 |
Long-Term Investments | 261.03 | 217.85 | 63.61 | 73.87 | 75.12 |
Other Intangible Assets | 394.15 | 699.16 | 719.58 | 748.63 | 764.56 |
Long-Term Deferred Tax Assets | 110.83 | 91.85 | 59.1 | 42.16 | 21.67 |
Long-Term Deferred Charges | 21.23 | 1.74 | 3.17 | 2.58 | 9.98 |
Other Long-Term Assets | 658.56 | 15.76 | 308.41 | 469.07 | 530.38 |
Total Assets | 4,613 | 5,063 | 4,454 | 4,094 | 3,762 |
Accounts Payable | 188.12 | 253.14 | 178.15 | 152.94 | 154.46 |
Accrued Expenses | 209.28 | 167.8 | 156.78 | 156.8 | 104.95 |
Short-Term Debt | 395 | 790.1 | 100.07 | 100 | - |
Current Portion of Long-Term Debt | - | - | 148.1 | 2.1 | - |
Current Portion of Leases | 0.83 | 2.36 | 4.05 | 8.65 | 4.79 |
Current Income Taxes Payable | 20.69 | 32.67 | 15.45 | 27.98 | 24.76 |
Current Unearned Revenue | 184.82 | 195.12 | 240.4 | 94.53 | 144.57 |
Other Current Liabilities | 200.08 | 155.34 | 167.19 | 125.47 | 143.02 |
Total Current Liabilities | 1,199 | 1,597 | 1,010 | 668.47 | 576.55 |
Long-Term Debt | - | - | - | 148 | - |
Long-Term Leases | 1.98 | 1.5 | 3.25 | 11.68 | 14.68 |
Long-Term Unearned Revenue | 4.24 | 5.39 | 6.16 | 5.56 | 9.51 |
Long-Term Deferred Tax Liabilities | 14.25 | 12.26 | 15.23 | 7.85 | 2.45 |
Other Long-Term Liabilities | - | 0.36 | 0.36 | - | - |
Total Liabilities | 1,219 | 1,616 | 1,035 | 841.56 | 603.19 |
Common Stock | 401 | 401 | 401 | 401.44 | 401.82 |
Additional Paid-In Capital | 765.28 | 761 | 760.45 | 774.49 | 780.12 |
Retained Earnings | 2,167 | 2,220 | 2,187 | 2,028 | 1,930 |
Treasury Stock | - | - | - | -14.47 | -26.66 |
Comprehensive Income & Other | -1.73 | -1.71 | -1.58 | -1.49 | -1.28 |
Total Common Equity | 3,331 | 3,380 | 3,347 | 3,188 | 3,084 |
Minority Interest | 63.02 | 66.1 | 71.42 | 64.51 | 74.36 |
Shareholders' Equity | 3,394 | 3,447 | 3,419 | 3,253 | 3,158 |
Total Liabilities & Equity | 4,613 | 5,063 | 4,454 | 4,094 | 3,762 |
Total Debt | 397.81 | 793.97 | 255.48 | 270.44 | 19.47 |
Net Cash (Debt) | 1,396 | 1,678 | 1,869 | 1,574 | 1,640 |
Net Cash Growth | -16.82% | -10.22% | 18.75% | -4.03% | -31.21% |
Net Cash Per Share | 3.50 | 4.17 | 4.68 | 3.89 | 4.10 |
Filing Date Shares Outstanding | 401 | 401 | 401 | 401.44 | 401.82 |
Total Common Shares Outstanding | 401 | 401 | 401 | 401.44 | 401.82 |
Working Capital | 1,037 | 1,358 | 1,520 | 1,569 | 1,399 |
Book Value Per Share | 8.31 | 8.43 | 8.35 | 7.94 | 7.68 |
Tangible Book Value | 2,937 | 2,681 | 2,628 | 2,439 | 2,320 |
Tangible Book Value Per Share | 7.32 | 6.69 | 6.55 | 6.08 | 5.77 |
Buildings | 911.4 | 507.12 | 476.51 | 274.43 | 274.43 |
Machinery | 108.26 | 93.04 | 85.39 | 73.52 | 63.46 |
Construction In Progress | 22.89 | 603.06 | 309.48 | 253.24 | 118.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.